News, Analysis & Insights on Nutrition, Supplements, and Health
EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA) has rejected two health claims dossiers claiming a link between curcumin and joint function and an extract for sperm DNA damage.
Supplementation with vitamin D ‘is unlikely’ to reduce the risk of asthma, atopic dermatitis, or allergies, a new genetic study has found.
Antioxidants from grape powder helped ease hyperglycaemia-related cognitive dysfunction in aged rats, a study discovered.
VITAFOODS 2017
Caramel bars, chocolate shakes and popping candy were among the indulgent supplement delivery forms showcased by Glanbia Nutritionals at last week’s Vitafoods.
A study using a DuPont probiotic strain showed a modest effect on the inflammatory response in the nose in response to an infection with a common cold virus.
Mazza Innovation is gaining increasing attention in dietary supplement circles, with its technology offering an environmentally friendly, solvent-free way of extracting compounds like polyphenols, alkaloids, glycosides, and specialty carbohydrates.
A move by newly confirmed FDA commissioner Scott Gottlieb to reapportion FDA inspectors along lines of expertise has been welcomed as potentially improving the effectiveness of the inspection process.
Royal DSM, global ingredients player, has announced it will make an equity investment into industrial bioscience company Amyris.
Health promotion campaigns are failing to reduce obesity in adolescents, according to a report published by World Health Organization (WHO) today.
New research from Japan has shown that drinking green tea can reduce the risk of diabetes caused by rice consumption among women.
Innovation is booming in Australia and New Zealand’s vitamins and dietary supplements sector with companies rolling out scores of new products over the past five years, according to new research.
China’s infant milk formula market is poised to boom in the next five years as a result of the new “two-child” policy, and tighter rules issued by regulators, analysts said today.
A cash injection upwards of $4.5m will help propel Premama into the forefront of non-pill prenatal nutrition, says president and founder Dan Aziz.